CHD Chemicals Q1 FY27 loss narrows; audit update

Stock snapshot and why the update matters

CHD Chemicals Ltd was trading at ₹5.46 as of 7 Sep, 2026. The company has been in focus after a sequence of regulatory filings covering quarterly results, changes on the board, and audit-related disclosures.

A key near-term trigger was the company’s Q1 FY27 (quarter ended June 30, 2026) financial update that was taken up by the board in August. Investors are also tracking the audit framework used for reporting, especially after the company’s FY26 audit carried an adverse opinion linked to Ind AS compliance.

Board meeting for Q1 FY27 results: what was scheduled

CHD Chemicals informed the BSE that its board meeting was scheduled for August 14, 2026 to consider and approve Q1 FY27 financial results. The company stated that the results relate to the quarter ended June 30, 2026.

The intimation timestamp in the material provided is Aug 11, 2026 15:45:42. The disclosure ties the board agenda directly to approving the quarterly numbers.

Q1 FY27 financial outcome: loss narrows year-on-year

For Q1 FY27, CHD Chemicals reported a net loss of ₹0.1227 crore (₹12.27 lakh). This compares with a net loss of ₹0.1543 crore (₹15.43 lakh) in the same period of FY26.

On the prior-year quarter detail available in the dataset, the company had reported Q1 FY26 revenue of ₹1.2689 crore (₹126.89 lakh), with the auditors issuing an unmodified opinion for that quarter.

Board approval and limited review: key compliance points

The company said its Board of Directors approved the unaudited financial results in the meeting held on August 14, 2026. It also stated that the results were reviewed by GAMS & Associates LLP, Chartered Accountants, under Standard on Review Engagement (SRE) 2410.

CHD Chemicals further disclosed that the statement was prepared in accordance with Indian Accounting Standards (Ind AS). In the same quarterly compliance update, the company reported no shareholder complaints or grievances received during the period and none pending as of June 30, 2026.

Director resignation: change in board composition

CHD Chemicals accepted the resignation of Mrs. Santosh Rani as a Non-Executive, Non-Independent Director, effective June 22, 2026. The resignation was attributed to personal reasons and other commitments, and it was stated to be effective immediately from the mentioned date.

Such board changes are typically disclosed to exchanges to keep shareholders informed about governance and oversight continuity.

FY26 numbers in context: revenue drop and wider loss

In a separate FY26 update, CHD Chemicals reported that its net loss widened to ₹31.38 crore for FY26, compared with a loss of ₹19.64 crore in FY25. The company also reported that revenue from operations fell 23.7% to ₹525.32 crore in FY26, from ₹688.45 crore in FY25.

The company’s total income was reported at ₹560.53 crore for FY26, compared with ₹709.79 crore in FY25. Basic EPS was stated as (₹0.31) in FY26 versus (₹0.19) in FY25.

For Q4 FY26 (quarter ended March 31, 2026), CHD Chemicals reported a net loss of ₹1.66 crore, compared with a profit of ₹6.57 crore in Q4 FY25. Revenue for Q4 FY26 was ₹153.26 crore, compared with ₹143.68 crore in Q4 FY25.

Auditor’s adverse opinion on FY26: what the filing said

The statutory auditor, GAMS & Associates LLP, issued an adverse opinion on the standalone financial statements for FY26. The stated reason was that the company prepared its financial statements in accordance with Accounting Standards specified under Section 133 of the Companies Act, 2013, rather than the mandated Ind AS.

As described in the filing, this meant the financial statements did not provide a true and fair view because they were not prepared using the applicable financial reporting framework.

Shareholders approve new statutory auditor at EGM

CHD Chemicals held an Extra Ordinary General Meeting (EGM) on May 4, 2026 through VC/OAVM to fill a casual vacancy in the statutory auditor role, following the resignation of M/s DSP & Associates.

Shareholders approved the appointment of M/s Gams & Associates LLP (ICAI Firm Registration No. N500094) with 2,229,745 votes (94.89%) in favour out of 2,349,745 total valid votes. The appointed auditor will hold office until the ensuing AGM for FY 2025-2026.

Key facts table

Market relevance: what investors typically watch next

For micro-cap companies, investors generally track whether quarterly disclosures remain timely and consistent, and whether audit observations narrow over time. In CHD Chemicals’ case, filings highlight both the shift to Ind AS for the quarterly statement and the presence of a prior adverse audit opinion on the FY26 standalone financials.

Separately, the governance updates around auditor appointment and a board resignation add to the set of compliance signals that market participants often use to assess reporting processes.

Conclusion

CHD Chemicals’ disclosures show a narrower Q1 FY27 loss versus the year-ago quarter, alongside confirmation of board approval and a limited review by GAMS & Associates LLP under SRE 2410. The updates come against the backdrop of FY26’s wider loss, a revenue decline, and an adverse audit opinion linked to the financial reporting framework used.

The next set of verified signals for investors will likely come through subsequent exchange filings, including any further board updates, audit-related clarifications, and future quarterly financial releases.